Product Details:
|
Product Name: | High Sensitivity CK-MB Quantitative Detection Kit (TRFIA) | Specification: | 20 Tests/box |
---|---|---|---|
Certificate: | ISO13485, CFDA | Specimen: | Whole Blood, Plasma, Serum |
Storing Temperature: | 2℃-8℃ | Shelf Life: | 18 Months |
Place Of Origin: | Jiangsu,China | Production Capacity: | 100,000 Tests/day |
Technology: | TRFIA | OEM: | Available |
High Light: | ck mb test kit 20 tests/box,cFDA ck mb test kit,whole blood poc test kit |
High sensitivity cFDA approved CK-MB Quantitative Detection Kit (TRFIA)
1. Product Description
Principle: Based on time-resolved fluorescence immunochromatography, the CK-MB Test Kit (Time Resolved Fluorescence Immunochromatographic Assay) was used to quantitatively determine the concentration of CK-MB in blood samples. When the sample was added to the reagent card, the CK-MB in the sample combines with the fluorescent microspheres which coupled with mouse anti human CKMB monoclonal antibody on the marker pad to form a complex. The complex flowed to the detection band containing another mouse anti human CK-MB monoclonal antibodies on the nitrocellulose membrane by chromatography, and was captured to form a double antibody sandwich complex. As a result, the more CK-MB in the sample, the more complex accumulation on the detection band. The excess unreacted fluorescent microspheres continued to be chromatographic to the control line. Fluorescence intensity on the detection line reflects the content of captured CK-MB in the sample. The concentration of CK-MB in the sample was quantitatively reflected by the LTRIC-600/LTRIC-300 of the time-resolved fluorescence immunoassay.
Intended Use:
This CK-MB Test Kit (Time Resolved Fluorescence Immunochromatographic Assay) is suitable for quantitative detection of Creatine kinase isoenzyme (abbreviated as CK-MB below)in human Serum/plasma/whole blood in vitro.
CK-MB is widely used as a diagnostic marker of myocardial injury in the detection of acute myocardial infarction (AMI). It is widely used in the detection of myocardial infarction. Clinical studies have shown that CK-MB release enters blood circulation during myocardial injury and peaks within 12~24 hours and returns to normal level within 48~72 hours. Therefore, the detection of CK-MB has great clinical significance for the diagnosis of AMI. The detection platform of this project mainly includes chemiluminescence technology, immunocompetency technology, colloidal gold technology, immunofluorescence technology, time-resolved fluorescence technology and so on.
2. Specification
Product Name | High sensitivity cFDA approved SAA Quantitative Detection Kit (TRFIA) |
Specification | 20 tests/box |
Sample | Whole blood, Plasma, Serum |
Storage Temperature | 2℃-8℃ |
Certificate | ISO13485/cFDA |
Place of Origin | Suzhou, Jiangsu, China |
MOQ | Negotiable, Accept small quantity |
Lead Time | Depends on the order, 1~15 working days |
Tips | Best to inquire for shipping details. We will contact you within 24 hours. Door to door service can be provided in some areas. |
3. High sensitivity cFDA approved CK-MB Quantitative Detection Kit (TRFIA) Main component
4. Storage conditions and expiry date?
The unopened kit can be stored in 2℃~8℃ for 18 months. The reagent card sealed in the aluminum foil bag package can be stored at temperature (2℃~30℃) for 30 days if it does not exceed expiry printed on the aluminum foil bag package. The temperature change during transportation (<37℃) has no effect on product quality. The reagent strip after the aluminum foil bag is unsealed can be stabilized for 1 hour at room temperature.
Contact Person: Bonnie
Tel: 86-13814877381